12 November 2020 in Lupus
Background: Juvenile onset systemic lupus erythematosus JO-SLE patients usually exhibit a more aggressive disease course compared to adult patients. Vitamin D deficiency is proposed to be associated with increased disease activity and flares of numerous autoimmune diseases like SLE, rheumatoid arthritis, and scleroderma. Objective: To evaluate the level of IL-17, IFN-γ, and 25-OH Vit D in JO-SLE patients versus healthy controls, and determine the correlation of those inflammatory mediators with SLE disease activity and damage scores. Furthermore, to analyze the relationship between 25-OH Vit D levels with the inflammatory cytokines (IFN-γ and IL-17) in JO-SLE patients. Patients and methods: Fifty JO-SLE patients and 25 controls were included in this study. Clinical and laboratory data of patients at the time of the study were recorded. SLE disease activity and damage were assessed using the SLEDAI-2K disease score and SLICC damage index, respectively. Plasma 25-OH Vit D, IFN-γ, and IL-17 concentrations were determined using the human ELISA kit. Results: Plasma 25-OH Vit D levels (20 ng/mL) were significantly lower in JO-SLE patients compared to (31 ng/mL) controls (P = 0.014). Plasma levels of IFN-γ and IL-17 were significantly higher (163.5 and 25.5 pg./mL) in JO-SLE patients than (68.3 and 3 pg./mL) that of controls (P = 0.016 and P = 0.013). There was a significant negative correlation between 25-OH Vit D levels and SLEDAI-2K (R= -0.431) as well as IFN-γ (R= -0.471) plasma level (P = 0.022 and P = 0.027). Conclusion: IFN-γ and IL-17 were significantly higher in JO-SLE patients, while 25-OH Vit D was significantly lower compared to controls. There was a negative correlation between 25-OH Vit D and each of SLEDAI-2K and IFN-γ.
1 April 2021 in The Egyptian Rheumatologist
1 June 2021 in Pan Arab Journal of Neurosurgery
BACKGROUND: Sacroiliitis following lumbosacral fixation is an important cause of postoperative low back pain and should be properly diagnosed and managed to improve the short- and long-term postoperative outcomes. OBJECT: We aimed to assess the prevalence of sacroiliitis following lumbar fusion procedures and the possible options of treatment available for such complication. METHODS: In this retrospective cross-sectional study, 100 patients who underwent spinal fusion surgery were included and observed for the next 3 months following surgery to detect postoperative sacroiliitis. RESULTS: One hundred patients aged 23- 65 years were included in the current study, with a mean age of 43.1±5.7 years. Fifty seven percent were females and 43% were males. Forty-seven patients (47%), 22 females (46.8%) and 25 males (53.2%), experienced sacroiliitis after a duration of 23.7 to 71 days post-operative with a mean of 33.8±1.7 days post-operative. Muscle relaxants and non-steroidal anti-inflammatory drugs (NSAID) were prescribed to all patients; 26 out of 47 patients (55%) responded well to medical treatment for 28 days with reduction of pain visual analogue scale (PVAS) from 7.3±2.1 to 3.3±1.4. In 21 patients (45%), medical treatment failed and physiotherapy sessions were added to medical treatment for 28 days with improvement of PVAS from 6.5±1 after 28 days medical treatment to 2.9±1.9 after medical treatment plus physiotherapy sessions. Five patients needed intra-articular steroid injection with further improvement of PVAS to <1. CONCLUSION: Sacroiliitis is an important cause of low back pain post lumbar fixation. Sacroiliitis is a frequent complication after lumbar fusion surgery detected in 47% of our study group. It was successfully managed with NSAIDs and physiotherapy in most of the cases.
24 December 2021 in Archives of Rheumatology
Objectives: This study aims to evaluate the expression pattern of factor H in peripheral blood and the frequency of factor H autoantibodies in plasma of juvenile-onset systemic lupus erythematosus (jSLE) patients compared to healthy controls. Patients and methods: Between March 2019 and October 2019, a total of 30 healthy individuals (3 males, 27 females; mean age: 26±7.4 years; range, 18 to 40 years) and 65 jSLE patients (age of onset ≤16 years) (2 males, 63 females; mean age: 23.4±7 years; range, 15 to 38 years) were included. Factor H expression pattern was examined in blood of all subjects using quantitative real-time polymerase chain reaction and the frequency of factor H autoantibodies was estimated in plasma using enzyme-linked immunosorbent assay. Results: Factor H expression was significantly downregulated in jSLE patients compared to healthy controls (p
1 November 2023 in Current Rheumatology Reviews
Objective: One of the potential factors that cause systemic lupus erythematosus (SLE) development is autophagy. Immunity-related GTPase family M protein (IRGM) has been shown to be linked to immune-mediated diseases. The aim of the current study was to assess the role of the IRGM-autophagy gene in SLE susceptibility in an Egyptian population and its relation to lupus nephritis. Methods: A case-control study was conducted in which a total of 200 subjects (100SLE and 100 healthy controls) were enrolled. Two single-nucleotide polymorphisms (SNPs) (rs10065172 and rs4958847) were genotyped. Genotypes and alleles analysis was conducted to compare between cases and controls, as well as a stratification analysis was conducted on the presence or absence of lupus nephritis. Results: Among selected SNPs of IRGM, no association was found between both SNPs and SLE susceptibility. For rs10065172, the major expressed genotype was CC (61% and 71%) (Adj OR= 2.9, 95%= 0.545-15.5), followed by TC (34 % and 27%) (Adj OR= 1.985, 95%= 0.357-11.041) in cases and controls, respectively. For rs4958847, AA and AG were comparably expressed in case [(43% and 39%) (Adj OR= 1.073, 95%= 0.483-2.382)] and control [(41% and 43%) (Adj OR= 1.24, 95%= 0.557- 2.763)], respectively. Additionally, no relationship among both SNPs and gender, lupus nephritis, disease activity, or disease duration, was observed. Conclusion: IRGM SNPs (rs10065172 and rs4958847) expression was comparable among SLE patients and controls of the Egyptian cohort. Genotype and allele frequency of IRGM SNPs did not differ in lupus nephritis and non-lupus nephritis patients.